Several lines of evidence (1) (2) (3) (4) (5) (6) (7) (8) (9) , including preceding studies from our laboratories (4, lo) , suggest that biotin deficiency causes abnormalities in fatty acid metabolism that are reflected in abnormalities in tissue fatty acid composition in man and in the rat. In the present study, we sought to determine which of the abnormalities observed in patients who developed biotin deficiency during parenteral nutrition would be replicated in an animal model of biotin deficiency and hence could be attributed to biotin deficiency per se. We also measured the time course of these abnormalities and of several biochemical parameters reflecting biotin nutritional status to determine whether these fatty acid abnormalities are markers for a lesser degree or an earlier stage of biotin deficiency.
METHODS
Male Sprague-Dawley rats of weanling age (approximately 28 days, 50-70 g) were purchased from Harlan Sprague-Dawley, Inc. (Madison, WI). Rats were housed in hanging wire, stainless steel cages, fed Purina Rodent Laboratory Chow ad libitum (Ralston Purina, St. Louis, MO), and given tap water ad libitum for 6 days until initiation of the experiment. At that time, 38 rats were randomly assigned to one of two treatment groups. The first group (BD) received Teklad diet no. 8 1079 ad libitum. The diet contained 30% spray-dried egg white, an amount that had reliably induced biotin deficiency previously as judged by urinary biotin excretion, by plasma concentrations of biotin, and by the appearance of the classical physical findings of biotin deficiency in the rat (1 I). The second group of rats (BT) were randomly paired to those in the BD group and pair-fed the same diet. The BT group received 250 pg of biotin dissolved in 1.25 ml of vehicle (0.0 1 M sodium bicarbonate) by interperitoneal injection twice weekly. The BD group received injections of vehicle only.
Ten pairs of rats (a BD rat and its pair-fed BT rat) were randomly chosen for 24-h urine collections at wk 2, 4, 6, 8, and 12. The rats were housed in metabolic cages designed to prevent fecal contamination of urine; in the rare instance when gross contamination was noted, the urine sample was discarded. During the 24-h collections, rats were allowed water ad libitum, but food was removed to prevent contamination of the urine with food (particularly with avidin). Studies from our laboratory demonstrate that contamination of urine by this egg white diet reduces the biotin detectable by our 1251-avidin binding assay (Mock DM, unpublished data) . After completing the urine collections at 4, 6 , and 8 wk, three pairs of rats were randomly chosen for sacrifice by exsanguination via the abdominal aorta after anesthesia with pentobarbital. At 12 wk, all of the remaining rats were killed. After death, the livers and hearts were immediately removed, weighed, frozen in liquid nitrogen, and stored at -70" C. Plasma was separated from blood and stored at -20" C.
Portions of the plasma, liver, and heart were shipped on dry ice to the Hormel Institute, Austin, MN for fatty acid analysis. Three pairs of uncontaminated urine samples at each time point and three pairs of serum samples at wk 12 were randomly selected for measurement of biotin concentration with the '251-avidin assay of Mock and DuBois (1 2). Hepatic activities of the biotindependent enzymes propionyl-CoA carboxylase (EC 6.4.1.3) and methylcrotonyl-CoA carboxylase (EC 6.4.1.4) were assayed according to the method of Weyler et al. (1 3) .
Fatty acid analysis. Lipids were extracted and the PL fraction was separated by thin-layer chromatography. The PL were converted to methyl esters, and the FAME were analyzed by capillary gas chromatography using methods described previously (10) .
All results are tabulated as the mean + SD of the triplicate values.
STATISTICAL ANALYSIS
Fatty acid data were analyzed by two-way ANOVA using treatment (BD or BT) as one variable and time on the diet as the other. To confirm the expected increase in odd-chain fatty acids, one-tailed analysis was performed. Two-tailed analysis was used for all other comparisons. An n of 3 at each time point was used for the ANOVA; the data for the three pairs at 12 wk were chosen at random from the larger number of pairs sacrificed. A significant effect of treatment without an accompanying significant interaction between treatment and time was interpreted as evidence of an abnormality that was caused by biotin deficiency but was not becoming significantly more abnormal during the period of the study. A significant interaction of treatment with time was taken as evidence of an abnormality that was caused by biotin deficiency and that progressed with time on the egg white diet. A significant effect of time alone was taken as evidence of a phenomenon not related to biotin deficiency (e.g. maturational effect, dietary change from Chow to egg white diet, etc.).
To compare our findings to a previous publication of Kramer et al. (4) , Student's two-tailed paired t tests were performed on fatty acid data of all pairs at wk 12, if suitable samples had been obtained at death. Student's two-tailed paired t tests were also used to test differences in plasma concentrations of biotin. A critical value of p < 0.05 was chosen as significant for both ANOVA and t testing.
RESULTS
Evidence ofprogressive biotin deficiency. The urinary excretion of biotin in the BD group decreased dramatically with time on the egg white diet (Fig. 1) . In the BT group, urinary biotin increased with time ( Table I ), suggesting that parenteral biotin supplement substantially exceeded that absorbed during the base- 4 6 8 10 12 Time (weeks) line period of Chow feeding. The mean plasma concentration of biotin at the termination of the study (wk 12) was significantly less ( p < 0.0016) in the BD group (2.2 f 1.5 pmol/ml, n = 3) than in the BT group (29 f 7 pmol/ml, n = 3). After 4 wk on the egg white diet, the mean hepatic activities of two biotindependent carboxylases (PCC and MCC) of the BD group had declined to about 25% of the mean of the BT group and did not decline further in the subsequent 8 wk (Fig. 2) *Biotin excretion in urine as measured by I2%avidin assay in rats fed a diet containing raw egg white, but receiving twice weekly injections of biotin. All values are mean + SD of n = 3 except wk 0 which is n = 2. Table 2 .
the rats in the BD group were showing early periocular hair loss and mandibular lesions. By the 6th wk, all rats in the BD group were showing mandible lesions and loss of large amounts of hair. The ataxia and kangaroo gait were present in the majority of the BD animals by 12 wk. In the BT group, no signs of biotin deficiency were present at any time during the study.
Evidence for changes in fatty acid composition.' Odd-chain fatty acids (15:0, 17:O) in plasma and liver PL were highly significantly increased in the BD group relative to the BT group ( Fig. 3 ; Table 2 ). The increase was evident at 4 wk and did not change significantly over the next 8 wk. In heart PL, 17:O was significantly increased, and, for 15:0, a significant interaction of treatment with time was detected.
Linoleic acid (1 8:206) was significantly increased in PL from liver but not plasma or heart when the BD group was compared to the BT group ( Fig. 4A ; Table 3 ). In all three tissues, significant increases with time, independent of treatment effects, were also detected.
The subsequent intermediates in the 06 pathway are the product of chain elongation of linoleic acid (20:2w6), the product of desaturation of linoleic acid (18:306, y-linolenic acid), and the product of chain elongation of 18:3w6 (20:3w6). These are minor components of the total fatty acid profile. Data are pro- (20:406) , no significant treatment effects were detected. In all three tissues, 22:506 (the elongation and desaturation product of 20:4w6) tended to decrease in BD compared to BT; significance was reached in plasma and liver (Fig. 4B ). For 22:5w6 in plasma PL, a significant interaction of treatment with time was also Full tabular data for all determinations are in appendix following references. detected (Table 3) . Figure 3 . Results of analysis of variance are presented in Table 3 .
Four intermediates in the w3 family of polyunsaturated fatty Table 3 . Sign$cance of dzfferences between BD and BT rats for acids were measured: these were 18:3w3 (linolenic acid), 2 0 5~3 , 06 fattv acids -. The data presented here provide evidence that biotin deficiency causes characteristic abnormalities in the fatty acid composition of PL in plasma, liver, and heart. The content of one or both of the two odd-chain fatty acids, 15:0, and 17:0, were significantly increased in all three tissues studied; plasma and liver had the most striking differences. Significant abnormalities were also detected in several of the w6 intermediates in PL from plasma and liver. These gross abnormalities of composition could lead to abnormalities in prostaglandin composition or production, particularly if a given lipid subclass (e.g. phosphatidyl choline) is selectively affected. For the w3 intermediates measured, biotin deficiency caused an increase in the percentage composition of 22:5w3 in plasma and heart PL, and an increase in heart PL 22:6w3 in the interaction of treatment with time.
In the documented cases of inadvertent biotin deficiency in man, the signs and symptoms of biotin deficiency typically required months to years to develop (14-2 1). In studies of biotin deficiency induced experimentally in man and in the rat, the characteristic findings tend to appear after about 6 wk (1, 3-8).
In our study, the earliest cutaneous manifestations were noted by 4 wk, but were not uniformly and strikingly present until 6 wk. By the 6th wk, the hepatic activities of propionyl-CoA carboxylase and methylcrotonyl-CoA carboxylase of the BD group had decreased to about 25% of the values for the BT group, and biotin concentrations of plasma and excretion in urine had decreased to 40 and lo%, respectively. We selected 4, 6, 8, and 12 wk as the time points for analysis of fatty acid composition. Surprisingly, substantial differences in fatty acid composition between the BD and BT groups were already present by 4 wk. This finding emphasizes recent observations (7, (22) (23) (24) (25) MOCK L that abnormalities in fatty acid composition can develop in a matter of a few weeks or less. Thus, the data from this study does not permit us to say when in the first 4 wk the abnormalities appeared. The timing relative to the onset of the cutaneous manifestations of biotin deficiency is consistent with the hypothesis than an abnormality (or abnormalities) in fatty acid metabolism may play a pathogenetic role in the cutaneous disease. Moreover, the early onset of abnormalities in 15:O and 17:O suggest that the composition of odd-chain fatty acids deserves further investigation as an early indicator of biotin status at the tissue level. This study was begun before the publication of similar studies by Kramer et al. (4) and Suchy et al. (6) . These two studies detected increases in the composition of odd-chain fatty acid, a finding confirmed in our study.
Our study also expands the information available. In the study of Suchy et al. (6) rats were not pair-fed and fatty acid compositions were determined at a single time point (12-14 wk) . The method of fatty acid analysis used by Suchy et al. (6) did not allow evaluation of the polyunsaturated fatty acids but did selectively evaluate saturated acids up to 27:O Suchy et al. (6) detected significant increases in all serum odd-chain fatty acids from 15:O to 27:O. The study of Kramer et al. (4) used a pair-fed design and found some abnormalities in fatty acid composition (especially in 22:5w6) that were due to the difference between pair and ad libitum feeding.
Our study also expands the study of Kramer et al. (4) in three important aspects. First, fatty acid composition was analyzed in three tissues (plasma, liver, and heart) rather than liver alone. Thus, comparison to clinical studies is facilitated. Second, serial sampling was done during progressive biotin deficiency rather than at a single time point. Thus, in the analysis of the data, we were able to evaluate differences due to treatment, trends in time not due to biotin deficiency, and interactions of treatment with time. Third, the temporal relationship of the fatty acid abnormalities to biotin nutritional status was assessed by measurement of hepatic carboxylase activities and urinary excretion of biotin. The current study confirms the findings of Kramer et al. (4) that biotin deficiency causes an increase in the odd-chain fatty acids 15:O and 17:O in liver PL. Increases of these fatty acids were also demonstrated in plasma and heart PL in this study suggesting a generalized abnormality in PL composition. The current study also confirms the finding of Kramer et al. (4) that biotin deficiency causes an increase in 18:2w6 in liver PL. A similar change was found in both plasma and heart PL, but only the abnormality in plasma PL reached statistical significance. A significant increase in 18:3w6 of plasma and liver PL was detected in the current study; 18:3w6 data were not reported by Kramer et al. (4) . The data of the current study did not confirm the Kramer et al. (4) finding of a significant decrease in 20:3w6 of liver PL, but a trend toward a decrease was apparently present. Our study detected a decrease in 22:5w6 in both plasma and liver that was not found by Kramer et al. (4) . For w3 intermediates, Kramer et al. (4) detected significant increases in both 18:3w3 and 22:6w3. Similar trends were seen in the current study although significance was not reached for 18:3w3 in liver, heart, or plasma. A significant increase in plasma and heart PL occurred in 22:5w3 and 22:6w3. The study reported here and that of Kramer et al. (4) measured the effects of very similar treatments in the same species; yet some disagreements in results occurred. The study of Kramer et al. (4) evaluated fatty acid composition at a single time point (7 wk), whereas the current study measured trends in time from 4 to 12 wk. To provide a more direct comparison of the two studies, we used Student's paired t test to evaluate the differences in the content of the individual fatty acids from liver PL between pairs of BD and BT rats at a single time point (wk 12) in a fashion analogous to that of Kramer et al. (4) . We detected significant statistical differences for the same fatty acids identified as significantly different by two-way AnOVA with an exception:
22:5w6 showed no change by t test, but a decrease by ANOVA. In addition, t testing found significant differences in the comparison of 20:4w6 which decreased and 22:4w6 and 22:6w3 which both increased in the BD group relative to the BT group. These results and the direction of change are almost identical with the findings of Kramer et al. (4) . In summary, this method of comparison emphasizes the basic agreement between the findings of the two studies. A previous paper from this laboratory described the abnormalities of fatty acid composition of serum PL, triglyceride, cholesteryl esters, and free fatty acid in three subjects who were profoundly biotin deficient. Abnormal increases in odd-chain fatty acids occurred during biotin deficiency; with biotin supplementation, those abnormalities normalized or decreased toward normal. Our study in rats provides additional evidence that increased content of odd-chain fatty acids is the result of biotin deficiency per se.
In serum PL of the three patients with biotin deficiency, linoleic acid (18:2w6) decreased, 18:3w6 and 20:3w6 increased, arachidonic acid (20:4w6) remained normal, and 22:4w6 varied, with one patient having decreased amounts and two patients having increased amounts. Biotin treatment did not result in a consistent resolution in any of these abnormalities. In the current animal study, biotin deficiency significantly increased both linoleic acid (18:2w6) and 18:3w6 in plasma and liver, 20:3w6 and 20:4w6 did not change significantly in any tissue, and 2 2 5~6 , the chain elongation and desaturation product of arachidonic acid, decreased significantly in plasma and liver PL of BD rats. Thus the w6 abnormalities of the patients were not generally found in this animal study; indeed, for some intermediates, opposite effects were seen. Based on a comparison of the human and the rat studies, we are not able to determine if the differences in abnormalities in the w6 series are attributable to species differences or to other factors such as the differences in composition and/or route of administration of lipids or other nutrients.
The data presented here do not address the question of whether the fatty acid abnormalities have an etiologic role in any of the physical findings of biotin deficiency. The evidence is accumulating that essential fatty acid deficiency causes a scaly dermatitis and alopecia by affecting prostaglandin metabolism (26-29). One is tempted to speculate that the gross compositional abnormalities of w6 fatty acids observed in this study might lead to abnormalities in prostaglandin composition and might in turn cause the cutaneous manifestations of biotin deficiency. Our ongoing studies of the effect of essential fatty acid on the cutaneous manifestations provide evidence for such a functional role (30). 1981 * Data for the composition of the w9 fatty acids are tabulated as mean f SD. Significance from two-way ANOVA is expressed as p values for treatment, time, and interaction of treatment with time. Zero values indicate fatty acid was less than the limit of detectability at 0.01 %.
